| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1600108 | 重组全人抗肿瘤坏死因子α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2017-04-13 | 深圳龙瑞药业有限公司 | Lonn Ryonn PHARMA Ltd | Certificate Issued | 2017-12-11 | view |